default author photo

Nadia Allahyarzadeh Khiabani

Tabriz University of Medical Sciences

Tabriz

Iran

  • Tabriz University of Medical Sciences

SCHOLARLY PAPERS

2

DOWNLOADS

144

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Combination of B7H6-siRNA and Temozolomide Synergistically Reduces Stemness and Migration Properties of Glioblastoma Cancer Cells: Promising Combination Treatment Against GBM

Number of pages: 23 Posted: 28 Jun 2022
Nadia Allahyarzadeh Khiabani, Mohammad Amin Doustvandi, Fateme Mohammadnejad, Elnaz Salmani Hassan Kohal, Neda Boushehri, Ahad Mokhtarzadeh, Mahdi Jafarlou and Behzad Baradaran
Tabriz University of Medical Sciences, Tabriz University of Medical Sciences - Immunology Research Center, Tabriz University of Medical Sciences - Immunology Research Center, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences - Immunology Research Center, Tabriz University of Medical Sciences and Tabriz University of Medical Sciences - Immunology Research Center
Downloads 95 (715,072)

Abstract:

Loading...

Glioblastoma, Temozolomide, B7H6-siRNA, Combination Therapy, cancer stem cells

2.

Targeting Pd-L1 Combined with Paclitaxel Hampers Gastric Cancer Progression by Modulating Cell Proliferation, Apoptosis, and Migration

Number of pages: 24 Posted: 23 Jul 2024
Elaheh Zafari, Amir Baghbanzadeh, Ahad Mokhtarzadeh, Leili Aghebati Maleki, Elham Baghbani, Sahar Safaei, Nadia Allahyarzadeh Khiabani, Parya Divsalar, Souzan Najafi and Behzad Baradaran
Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences, Tabriz University of Medical Sciences and Tabriz University of Medical Sciences - Immunology Research Center
Downloads 49 (1,074,648)

Abstract:

Loading...

gastric cancer, paclitaxel, PD-L1-siRNA, Combination Therapy